Wyoming Attorney General announces insulin product settlement with SanofiAventis U.S. LLC
by Office of the Attorney General
October 5, 2024
October 4, 2024 (Cheyenne) — Attorney General Bridget Hill announced a settlement with Sanofi-Aventis U.S. LLC (Sanofi) which guarantees that Wyoming citizens not enrolled in government health care programs can buy Sanofi’s insulin products for $35 per month for the next five years.
The soaring cost of insulin over the last decade has increased scrutiny on insulin manufacturers and pharmacy benefits managers from the Attorney General’s Office and other attorneys general around the nation. Concerns arose regarding whether insulin manufacturers deceptively priced their insulin products, requiring citizens to pay inordinately high prices for insulin. This settlement is a result of those concerns.
The terms of the settlement will come into effect within 90 days of September 27, 2024. The settlement requires Sanofi to provide insulin products—including Admelog, Lantus, Toujeo, and Apidra, and any biosimilar of those products that Sanofi markets in the U.S.—at $35 per monthly prescription for customers choosing to pay with cash.
To take advantage of the pricing, consumers will need to register for a savings card on a Sanofi affordability website. Once Sanofi’s affordability program is in place for Wyoming, the Attorney General’s Office will release additional information about how Wyoming citizens can purchase a month’s supply of Sanofi insulin for just $35.
In addition to the $35 monthly prescription rate, Sanofi has agreed to implement an enrollment message program to assist pharmacists and patients in determining eligibility for its low-cost insulin. The system will alert patients about this low-cost alternative at pharmacy counters throughout the State when patients are filling their prescriptions.
Lastly, Sanofi has also committed to continuing its Patient Connection Program that provides free insulin to Wyoming citizens in financial need. "This settlement is a good start to helping combat the problems surrounding insulin prices," Attorney General Hill said. "Consumers utilizing insulin have directly felt the impacts of skyrocketing insulin prices for years. For example, in 2018, the list price of a five-pack of Apidra in an injection pen was over $625. With this settlement, the price for a month’s supply of pens is only $35 for cash customers. I believe this settlement will greatly help Wyoming families needing insulin so they can better live their lives without fear of being able to afford a critical component of their care."
In the months ahead, the Attorney General’s Office intends to raise public awareness of the low-cost option afforded by this settlement. The Attorney General’s Office will also reach out to Wyoming pharmacies to raise awareness of the program and ensure Wyomingites who use insulin products can take advantage of the benefit of this settlement. At the same time, the Attorney General’s Office will continue to scrutinize the causes of the rising cost of insulin including looking at other drug manufacturers and pharmacy benefit managers and their impact on Wyoming consumers.
|
